Search Results - "Allum, W"

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Smyth, E C, Verheij, M, Allum, W, Cunningham, D, Cervantes, A, Arnold, D

Get full text

Quality assurance in upper GI cancer by Allum, W.

Get full text

Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Waddell, T, Verheij, M, Allum, W, Cunningham, D, Cervantes, A, Arnold, D

Get full text

Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma by Mariette, C., Carneiro, F., Grabsch, H. I., van der Post, R. S., Allum, W., de Manzoni, Giovanni

“…Background and aims Clinicopathological characteristics of gastric cancer (GC) are changing, especially in the West with a decreasing incidence of distal,…”
Get full text

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Okines, A., Verheij, M., Allum, W., Cunningham, D., Cervantes, A.

Get full text

Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up by Waddell, T, Verheij, M, Allum, W, Cunningham, D, Cervantes, A, Arnold, D

Get full text

Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma by Davies, A. R., Myoteri, D., Zylstra, J., Baker, C. R., Wulaningsih, W., Van Hemelrijck, M., Maisey, N., Allum, W. H., Smyth, E., Gossage, J. A., Lagergren, J., Cunningham, D., Green, M., Kelly, M., Ngan, S., Qureshi, A., Gaya, A., Griffin, N., Jacques, A., Goh, V., Deere, H., Chang, F., Mahadeva, U., Gill‐Barman, B., George, S., Dunn, J., Zeki, S., Meenan, J., Hynes, O., Tham, G., Iezzi, C., Dellaportas, D., Cowie, A., Knight, W., Valeri, N.

“…Background The aim was to define the pathological response in lymph nodes following neoadjuvant chemotherapy for oesophageal adenocarcinoma and to quantify any…”
Get full text

Differences in outcomes of oesophageal and gastric cancer surgery across Europe by Dikken, J. L., van Sandick, J. W., Allum, W. H., Johansson, J., Jensen, L. S., Putter, H., Coupland, V. H., Wouters, M. W. J. M., Lemmens, V. E. P., van de Velde, C. J. H.

“…Background: In several European countries, centralization of oesophagogastric cancer surgery has been realized and clinical audits initiated. The present study…”
Get full text

PG 9.01 Optimal surgery for gastric cancer: Is more always better? by Allum, W

Get full text

No need to develop a special interest category for emergency general surgery by Allum, W H, Griffiths, Gareth, Lund, Jon

“…The 2013 general surgery curriculum gives equal weight to the development of skills in a special interest and in emergency general surgery, recognising the…”
Get full text

The impact of obesity on esophagectomy: a meta-analysis by Mengardo, V, Pucetti, F, Mc Cormack, O, Chaudry, A, Allum, W H

“…The impact of body mass index (BMI) on postoperative outcomes after curative resection for esophageal cancer has been assessed in many studies worldwide with…”
Get full text

Guidelines for the management of oesophageal and gastric cancer by Allum, W H, Griffin, S M, Watson, A, Colin-Jones, D

Get full text

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial by Smyth, E.C., Nyamundanda, G., Cunningham, D., Fontana, E., Ragulan, C., Tan, I.B., Lin, S.J., Wotherspoon, A., Nankivell, M., Fassan, M., Lampis, A., Hahne, J.C., Davies, A.R., Lagergren, J., Gossage, J.A., Maisey, N., Green, M., Zylstra, J.L., Allum, W.H., Langley, R.E., Tan, P., Valeri, N., Sadanandam, A.

“…Following neoadjuvant chemotherapy for operable gastroesophageal cancer, lymph node metastasis is the only validated prognostic variable; however, within lymph…”
Get full text

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study by Hewitt, L.C., Inam, I.Z., Saito, Y., Yoshikawa, T., Quaas, A., Hoelscher, A., Bollschweiler, E., Fazzi, G.E., Melotte, V., Langley, R.E., Nankivell, M., Cunningham, D., Allum, W., Hutchins, G.G., Grabsch, H.I.

“…Oesophageal (OeC) and gastric (GC) cancer patients are treated with similar multimodal therapy and have poor survival. There remains an urgent clinical need to…”
Get full text

Effect of publishing surgeon‐specific outcomes on surgical training by Harries, R. L., Glasbey, J., Gokani, V. J., Griffiths, G., Allum, W.

“…Background Over the past 10 years, the National Health Service in England has started to publish surgeon‐specific outcomes publicly. The aim of this study was…”
Get full text

Variation in histopathological assessment and association with surgical quality indicators following oesophagectomy by Pucher, P H, Green, M, Bateman, A C, Underwood, T J, Maynard, N, Allum, W H, Novelli, M, Gossage, J A

“…Histopathological outcomes, such as lymph node yield and margin positivity, are used to benchmark and assess surgical centre quality, and are reported annually…”
Get full text

Surgical resection strategy and the influence of radicality on outcomes in oesophageal cancer by Davies, A. R., Sandhu, H., Pillai, A., Sinha, P., Mattsson, F., Forshaw, M. J., Gossage, J. A., Lagergren, J., Allum, W. H., Mason, R. C.

“…Background The optimal surgical approach to tumours of the oesophagus and oesophagogastric junction remains controversial. The principal randomized trial…”
Get full text

Lymphadenectomy for gastric cancer at European specialist centres by Bencivenga, M., Torroni, L., Verlato, G., Mengardo, V., Sacco, M., Allum, W.H., de Manzoni, G.

“…The aim of this project was to evaluate the current practice of D2 in Europe. In the first part of the study, 18 European high volume gastric cancer centres…”
Get full text

Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients by Messager, M, Neofytou, K, Chaudry, M.A, Allum, W.H

“…Abstract This study was designed to investigate the prognostic impact of elevated platelet to lymphocyte ratio (PLR) on survival for oesophageal and junctional…”
Get full text

Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report by Okines, A.F.C., Langley, R.E., Thompson, L.C., Stenning, S.P., Stevenson, L., Falk, S., Seymour, M., Coxon, F., Middleton, G.W., Smith, D., Evans, L., Slater, S., Waters, J., Ford, D., Hall, M., Iveson, T.J., Petty, R.D., Plummer, C., Allum, W.H., Blazeby, J.M., Griffin, M., Cunningham, D.

“…Peri-operative chemotherapy and surgery is a standard treatment of localised oesophagogastric adenocarcinoma; however, the outcomes remain poor. ST03 is a…”
Get full text